Table of Content

1 Human Vaccines Market Introduction and Overview
1.1 Human Vaccines Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Human Vaccines Industry Dynamic Analysis
1.5.1 Human Vaccines Market Trends Analysis
1.5.2 Human Vaccines Market Drivers Analysis
1.5.3 Human Vaccines Market Challenges Analysis
1.5.4 Human Vaccines Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Human Vaccines Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Human Vaccines Revenue and Share by Type
3 Global Human Vaccines Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Human Vaccines Revenue and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Human Vaccines Market Size (2019-2024)
4.2 Human Vaccines Growth Insights by Regions
4.2.1 Human Vaccines Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Human Vaccines Revenue Market Size by Regions (2019-2024)
4.2.3 North America Human Vaccines Market Size (2019-2024)
4.2.4 Europe Human Vaccines Market Size (2019-2024)
4.2.5 Asia-Pacific Human Vaccines Market Size (2019-2024)
4.2.6 Latin America Human Vaccines Market Size (2019-2024)
4.2.7 Middle East & Africa Human Vaccines Market Size (2019-2024)
5 North America
5.1 North America Human Vaccines Revenue by Countries
5.1.1 North America Human Vaccines Revenue by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Human Vaccines Revenue by Countries
6.1.1 Asia Pacific Human Vaccines Revenue by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Human Vaccines Revenue by Countries
7.1.1 Europe Human Vaccines Revenue by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Human Vaccines Revenue by Countries
8.1.1 Latin America Human Vaccines Revenue by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Human Vaccines Revenue by Countries
9.1.1 Middle East & Africa Human Vaccines Revenue by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Human Vaccines Market Competition, by Players
10.1 Global Human Vaccines Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Human Vaccines Players Market Share in 2023
10.2.2 Top 6 Human Vaccines Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Human Vaccines Players Head Office, Business Provided
10.4 Human Vaccines Mergers & Acquisitions
10.5 Human Vaccines New Entrants and Expansion Plans
11 Players Profiles
11.1 Merck
11.1.1 Merck Company Profile
11.1.2 Human Vaccines Product Overview
11.1.3 Merck Human Vaccines Market Performance (2019-2024)
11.1.4 Merck Business Overview
11.1.5 Recent Developments and Plans
11.2 Sinovac
11.2.1 Sinovac Company Profile
11.2.2 Human Vaccines Product Overview
11.2.3 Sinovac Human Vaccines Market Performance (2019-2024)
11.2.4 Sinovac Business Overview
11.2.5 Recent Developments and Plans
11.3 Emergent Biosolutions
11.3.1 Emergent Biosolutions Company Profile
11.3.2 Human Vaccines Product Overview
11.3.3 Emergent Biosolutions Human Vaccines Market Performance (2019-2024)
11.3.4 Emergent Biosolutions Business Overview
11.3.5 Recent Developments and Plans
11.4 Seqirus
11.4.1 Seqirus Company Profile
11.4.2 Human Vaccines Product Overview
11.4.3 Seqirus Human Vaccines Market Performance (2019-2024)
11.4.4 Seqirus Business Overview
11.4.5 Recent Developments and Plans
11.5 Bavarian Nordic
11.5.1 Bavarian Nordic Company Profile
11.5.2 Human Vaccines Product Overview
11.5.3 Bavarian Nordic Human Vaccines Market Performance (2019-2024)
11.5.4 Bavarian Nordic Business Overview
11.5.5 Recent Developments and Plans
11.6 Bharat Biotech
11.6.1 Bharat Biotech Company Profile
11.6.2 Human Vaccines Product Overview
11.6.3 Bharat Biotech Human Vaccines Market Performance (2019-2024)
11.6.4 Bharat Biotech Business Overview
11.6.5 Recent Developments and Plans
11.7 GlaxoSmithKline (GSK)
11.7.1 GlaxoSmithKline (GSK) Company Profile
11.7.2 Human Vaccines Product Overview
11.7.3 GlaxoSmithKline (GSK) Human Vaccines Market Performance (2019-2024)
11.7.4 GlaxoSmithKline (GSK) Business Overview
11.7.5 Recent Developments and Plans
11.8 Biological E. Limited
11.8.1 Biological E. Limited Company Profile
11.8.2 Human Vaccines Product Overview
11.8.3 Biological E. Limited Human Vaccines Market Performance (2019-2024)
11.8.4 Biological E. Limited Business Overview
11.8.5 Recent Developments and Plans
11.9 Pfizer
11.9.1 Pfizer Company Profile
11.9.2 Human Vaccines Product Overview
11.9.3 Pfizer Human Vaccines Market Performance (2019-2024)
11.9.4 Pfizer Business Overview
11.9.5 Recent Developments and Plans
11.10 Panacea Biotec
11.10.1 Panacea Biotec Company Profile
11.10.2 Human Vaccines Product Overview
11.10.3 Panacea Biotec Human Vaccines Market Performance (2019-2024)
11.10.4 Panacea Biotec Business Overview
11.10.5 Recent Developments and Plans
11.11 Sanofi Pasteur
11.11.1 Sanofi Pasteur Company Profile
11.11.2 Human Vaccines Product Overview
11.11.3 Sanofi Pasteur Human Vaccines Market Performance (2019-2024)
11.11.4 Sanofi Pasteur Business Overview
11.11.5 Recent Developments and Plans
12 Global Human Vaccines Forecast Market Insights by Type
12.1 Global Human Vaccines Revenue Market Forecast by Type (2024-2030)
13 Global Human Vaccines Forecast Market Insights by Application
13.1 Human Vaccines Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Insights
14.1 Global Human Vaccines Forecast Market Size (2024-2030)
14.2 Human Vaccines Growth Forecast Insights by Regions
14.2.1 Human Vaccines Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Human Vaccines Forecast Market Size (2024-2030)
14.2.3 Europe Human Vaccines Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Human Vaccines Forecast Market Size (2024-2030)
14.2.5 Latin America Human Vaccines Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Human Vaccines Forecast Market Size (2024-2030)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer